
Life Sciences Day on the Hill 2026 — Recap
February 12, 2026

BioUtah, in partnership with the Governor’s Office of Economic Opportunity, held the 2026 Life Sciences Day on the Hill at the Utah State Capitol in Salt Lake City on February 9.
Featuring exhibits from over 20 local companies, including medical device, diagnostics, and biotech companies, the event provided an opportunity for innovators to engage directly with state legislators to help them better understand how their technologies improve and save lives.
“The gathering turns the spotlight on our industry for a day of education and impactful conversations with policymakers,” said Kelvyn Cullimore, president and CEO of BioUtah. “As one of the fastest-growing healthcare innovation hubs in the nation, legislators learned about an array of new technologies that are changing patients’ lives.”
With more than $22B in GDP and more than 1,600 companies employing 180,000 Utahns, Utah’s life sciences industry has become a major force in the state’s economy.
This year’s Life Sciences Day on the Hill featured displays from over 20 companies, including:
• Altitude Lab
• Anziva Pharmaceuticals
• ARUP Laboratories
• ATL Technology
• Azunic
• BD
• bioMérieux, Inc.
• Blackrock Neurotech
• Breath of Life
• Co-Diagnostics, Inc.
• Curavit
• Discgenics
• Edwards Lifesciences
• Epitel
• Halia Therapeutics
• IBEX Clinical Research
• Kolosis BIO
• Merit Medical Systems
• Nelson Labs
• Nusano
• Path Fertility
• Stryker
• University of Utah
• UVU College of Science
Event Photo Gallery
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp


















































